(Total Views: 505)
Posted On: 02/08/2022 10:34:38 AM
Post# of 154148
"Then if it's similar to the only in vivo testing done how will the FDA view 42% efficacy?"
Based on recent history, it depends on who is making the decisions. At 42% efficacy, it should be well received, if either brain bleed or thrombosis are side effects.
Read More: https://investorshangout.com/post/view?id=633...z7KJj5ICZ3
Based on recent history, it depends on who is making the decisions. At 42% efficacy, it should be well received, if either brain bleed or thrombosis are side effects.
Read More: https://investorshangout.com/post/view?id=633...z7KJj5ICZ3
(3)
(0)
